Skip to content

Improving on a good start: Scotland examines its first four years of PrEP

Cumulative PrEP prescriptions in Scotland

Southern African HIV testing programmes have hit the 90% UNAIDS target for knowledge of status but testing rates are lower in key groups

Villagers line up to get tested for HIV in Uganda. Victoria Holdsworth/Commonwealth Secretariat. Creative Commons licence.

England's big PrEP implementation trial releases its enrolment data: young people under-represented

Image: The Gender Spectrum Collection. Images are for illustrative purposes only.

Testing homeless people during COVID-19 identifies several new HIV cases, especially in Black people

Binta Sultan of Find-and-Treat

A history of abuse has a lasting impact on HIV care engagement and health outcomes

panitanphoto/Shutterstock.com

Injectable HIV therapy would have to cost less than $131 a year to be cost-effective in Africa

funnyangel/Shutterstock.com

‘Resilient’ HIV programmes in African countries have maintained viral suppression during the COVID-19 pandemic

Dr Tiffany Harris presenting at CROI 2021.

Injectable HIV medications must be practical and affordable, conference hears

Carlos del Rio, Diane Havlir, Charles Flexner, Francois Venter, Hyman Scott, Nittaya Phanuphak (top to bottom, left to right) at CROI 2021.

To be cost-effective, injectable PrEP can only cost about $3000 more than US generic oral PrEP

Slide from Dr Anne Neilan's presentation to CROI 2021. Diagram shows prices of two different forms of PrEP where injectable PrEP is not cost-effective (red); cost-effective (yellow); and cost-saving (green).